Purchase Order 75N92023P00231
Award Date 8/1/23
Potential Completion Date 7/31/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart, Lung, and Blood Institute awarded a $13.3K firm fixed-price purchase order to Qiagen, LLC on August 1, 2024, for maintenance services on a QIAsymphony SP 34311 instrument. The contract, which runs through July 31, 2025, supports the laboratory's critical need to maintain equipment used for isolating cell-free DNA from plasma samples of lung transplant patients. This maintenance agreement ensures continued operational capability of the specialized molecular diagnostics...
- This is a $13,573.60 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The contract is for maintenance services on Qiagen's QIASYMPHONY SP 34311 equipment used to isolate cell-free DNA from lung transplant patient plasma samples. The contract period of performance is from August 1, 2025 to July 31, 2026. There is no...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Qiagen, LLC for $15,671.00 on October 30, 2013, with an ultimate completion date of October 30, 2014. Performance occurs in Bethesda, Maryland. The order carries firm fixed price terms and no set-aside designation. The specific requirements and deliverables are not detailed in the source material provided.</p>
- This is a $24,978.80 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, part of the Department of Health and Human Services, to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic products. The contract requires Qiagen to provide QIAsymphony DSP circulating DNA kits to isolate cell-free DNA from plasma samples from lung transplant patients. This is likely in support of the agency's biomedical research and public health programs. The...
- This firm-fixed-price purchase order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $24,882.55 contract is for the NHLBI's Laboratory of Applied Precision Omics to acquire Qiagen's QIAsymphony DSP Circulating DNA Kit to isolate cell-free DNA from plasma samples...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $17,690.79 firm fixed-price BPA call to Qiagen, LLC on December 17, 2025, for delivery by March 16, 2026. The contract supports the Laboratory Applied Precision Omics program, which requires the QIAsymphony DSP Circulating DNA Kit to isolate cell-free DNA (cfDNA) from plasma samples collected from lung transplant patients. This award was issued without a set-aside designation, allowing Qiagen to compete in the open federal...
- The Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute awarded a $80,572 purchase order to Qiagen, LLC for the EZ2 CONNECT SYSTEM. As a division of Qiagen N.V., Qiagen, LLC will deliver its EZ2 CONNECT SYSTEM product to the NIH/NHLBI over a one year period ending in September 2024. The firm fixed price contract was awarded without any set aside designations and will be performed at Qiagen's location in Bethesda, Maryland to support...
- The Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute awarded a $49,929 purchase order to Qiagen, LLC for QIACUITY polymerase chain reaction (PCR) machines. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor in fulfilling the contract requirements. The firm-fixed price contract runs from March 15, 2021 through March 14, 2022 and calls for the delivery of PCR machines to support research efforts...
- This is a $12,060 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is for maintenance services on Qiagen's EZ2 Connect and QIAcuity One instruments used for isolation and analysis of cell-free DNA. The contract has an ultimate completion date of August 15, 2026. Qiagen has established itself as a critical...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $35,650 on November 9, 2012, for critical function and LIHA service contract to maintain scientific equipment used for clinical research. Performance is in Bethesda, Maryland. The order was scheduled for ultimate completion on November 8, 2013. Pricing is firm fixed price.</p>